Children's cough medicine concerns leads to OTC drug act

Share this article:
Responding to concerns about cough medicines labeled for children, Sen. Edward Kennedy (D-MA) and Rep. Henry Waxman (D-CA) have introduced the Non-Prescription Drug Modernization Act to give the FDA authority to remove unsafe OTC drug products without proceeding with lengthy public rulemaking procedures.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...